MedPath
HSA Approval

VACOPAN INJECTION 20 mg/ml

SIN09563P

VACOPAN INJECTION 20 mg/ml

VACOPAN INJECTION 20 mg/ml

November 25, 1997

ATLANTIC PHARMACEUTICAL (S) PTE LTD

ATLANTIC PHARMACEUTICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence HolderATLANTIC PHARMACEUTICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

A03BB01

butylscopolamine

Manufacturer Information

atlantic pharmaceutical (s) pte ltd

ATLANTIC LABORATORIES CORPN LTD

Active Ingredients

HYOSCINE N-BUTYLBROMIDE

20 mg/ml

Scopolamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.